Echo Therapeutics Inc.

Echo Therapeutics Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$50.23 K
Shares Outstanding
12 M
Public Float
11.76 M

Profile

Address
99 Wood Avenue South
Iselin New Jersey 08830
United States
Employees -
Website http://www.echotx.com
Updated 07/08/2019
Echo Therapeutics, Inc. develops non-invasive, wireless, and continuous glucose monitoring system. It develops needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals. The company was founded on September 14, 2007 and is headquartered in Iselin, NJ.

Financials

View All

Alan Wayne Schoenbart
Chief Executive Officer, CFO, Secretary & Director
Alan Wayne Schoenbart
Chief Executive Officer, CFO, Secretary & Director